Propranolol

Major

Propranolol Abametapir Explained Increased exposure of CYP1A2 substrates Details Propranolol Albuterol Oral Inhalation Accuneb® Explained Reduced efficacy of albuterol Details Propranolol Capmatinib Tabrecta Increased CYP1A2 substrate exposure and an increased risk of adverse reactions Details Propranolol Clonidine Transdermal Patch Catapres An increased risk of worsen sinus node dysfunction and atrioventricular node conduction, an increased risk of bradycardia and AV b... Details Propranolol Dihydroergotamine Injection DHE-45® Injection Increased risk of coronary artery vasospasm Details Propranolol Dihydroergotamine Nasal Spray Migranal Increased risk of coronary artery vasospasm Details Propranolol Indacaterol Oral Inhalation Arcapta® Decreased efficacy of indacaterol Details Propranolol Lacosamide Injection Motpoly An increased risk of AV block, bradycardia, and ventricular tachyarrhythmia Details Propranolol Mefloquine Lariam® An increased risk of ECG abnormalities and cardiac arrest Details Propranolol Methylergonovine Methergine An increased risk of enhanced vasoconstrictive Details Propranolol Olodaterol Oral Inhalation Striverdi Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details

Moderate

Propranolol Omeprazole Gastrobim Explained Increased propranolol exposure Details Propranolol Sertraline Explained Increased propranolol exposure Details Propranolol Acarbose Prandase® Explained Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Asenapine Transdermal Patch Secuado An increased risk of hypotension Details Propranolol Aspirin Acuprin® Reduced antihypertensive effect Details Propranolol Aspirin Rectal Aspirin Reduced antihypertensive effect Details Propranolol Abiraterone Abirtega Increased propranolol exposure Details Propranolol Alfuzosin UroXatral An exaggerated hypotensive response to the first dose of the alpha blocker Details Propranolol Alogliptin Nesina Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Bromfenac Ophthalmic Bromday® Reduced antihypertensive effect Details Propranolol Canagliflozin Invokana Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Cholestyramine Resin Locholest® Decreased propranolol exposure Details Propranolol Colestipol Colestid Decreased propranolol effectiveness Details Propranolol Dapagliflozin Farxiga Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Diclofenac Ophthalmic Voltaren® Eye Drops Reduced antihypertensive effect Details Propranolol Diclofenac Topical (Actinic Keratosis) Pennsaid Reduced antihypertensive effect Details Propranolol Diclofenac Topical (Arthritis Pain) Pennsaid® Reduced antihypertensive effect Details Propranolol Diclofenac Transdermal Patch Flector Reduced antihypertensive effect Details Propranolol Digoxin Cardoxin® Increased risk of bradycardia and possible digitalis glycoside toxicity Details Propranolol Dobutamine Reduced sensitivity to DOBUTamine stress echocardiography Details Propranolol Doxazosin Cardura An exaggerated hypotensive response to the first dose of the alpha blocker Details Propranolol Dulaglutide Injection Trulicity Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Ertugliflozin Steglatro Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Esomeprazole Nexium Increased propranolol exposure Details Propranolol Esomeprazole Injection Nexium Increased propranolol exposure Details Propranolol Etodolac Lodine Reduced antihypertensive effect Details Propranolol Exenatide Injection Bydureon Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia Details Propranolol Fenoprofen Fenopron Reduced antihypertensive effect Details